I believe my position is accurate; JZ secured the deal with Pharmakon before the FDA reneged, not JT. The money JT raised with GS years later was earmarked for GIA. I checked our balance sheet on 12/31/13 we had $219 million in liquid assets, far from broke. No doubt JZ was stunned when the FDA reneged, a real gut punch none of us saw coming. I think JZ was so dismayed that's why he stepped down.